Eleven Therapeutics
https://www.eleventx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Eleven Therapeutics
Deal Watch: Sangamo Inks Significant Option Deal With Prevail After Losing Tie-Ups With Novartis, Biogen
Plus deals involving Novartis/DTx, Neurogene/Neoleukin, Travere/Mirum, Sanofi/Scribe, Korro Bio/Frequency, MaxCyte/viTToria and more.
Company Information
- Industry
- Biotechnology
- Digital Health
- Pharmaceuticals
-
Digital Health
- Artificial Intelligence
-
Biotechnology
- Antisense, Oligonucleotides
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice